TD Asset Management’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-472
Closed -$220K 1430
2023
Q1
$220K Sell
472
-996
-68% -$465K ﹤0.01% 1372
2022
Q4
$588K Buy
+1,468
New +$588K ﹤0.01% 1254
2021
Q2
Sell
-2,269
Closed -$1.97M 1538
2021
Q1
$1.97M Sell
2,269
-1,024
-31% -$889K ﹤0.01% 1112
2020
Q4
$3.05M Sell
3,293
-200
-6% -$185K ﹤0.01% 910
2020
Q3
$3.59M Buy
3,493
+420
+14% +$432K 0.01% 792
2020
Q2
$3.11M Buy
3,073
+1,456
+90% +$1.48M ﹤0.01% 770
2020
Q1
$1.41M Sell
1,617
-352
-18% -$306K ﹤0.01% 910
2019
Q4
$2.11M Sell
1,969
-92
-4% -$98.6K ﹤0.01% 914
2019
Q3
$1.91M Hold
2,061
﹤0.01% 917
2019
Q2
$2.33M Sell
2,061
-32
-2% -$36.1K ﹤0.01% 883
2019
Q1
$2.84M Buy
2,093
+236
+13% +$321K ﹤0.01% 830
2018
Q4
$2.15M Sell
1,857
-24
-1% -$27.8K ﹤0.01% 899
2018
Q3
$2.86M Buy
1,881
+24
+1% +$36.5K ﹤0.01% 899
2018
Q2
$2.91M Buy
1,857
+312
+20% +$488K ﹤0.01% 854
2018
Q1
$1.79M Buy
1,545
+228
+17% +$263K ﹤0.01% 908
2017
Q4
$1.56M Buy
1,317
+40
+3% +$47.4K ﹤0.01% 944
2017
Q3
$1.72M Buy
1,277
+245
+24% +$330K ﹤0.01% 911
2017
Q2
$833K Sell
1,032
-40
-4% -$32.3K ﹤0.01% 1088
2017
Q1
$661K Sell
1,072
-68
-6% -$41.9K ﹤0.01% 1144
2016
Q4
$610K Buy
1,140
+12
+1% +$6.42K ﹤0.01% 1138
2016
Q3
$584K Sell
1,128
-12
-1% -$6.21K ﹤0.01% 1141
2016
Q2
$468K Sell
1,140
-12
-1% -$4.93K ﹤0.01% 1133
2016
Q1
$613K Sell
1,152
-56
-5% -$29.8K ﹤0.01% 1060
2015
Q4
$920K Sell
1,208
-32
-3% -$24.4K ﹤0.01% 970
2015
Q3
$680K Buy
1,240
+60
+5% +$32.9K ﹤0.01% 1011
2015
Q2
$693K Buy
1,180
+52
+5% +$30.5K ﹤0.01% 1047
2015
Q1
$885K Buy
1,128
+96
+9% +$75.3K ﹤0.01% 974
2014
Q4
$705K Buy
+1,032
New +$705K ﹤0.01% 1012